tradingkey.logo
tradingkey.logo
검색

Nuwellis Inc

NUWE
관심 목록에 추가
3.150USD
+0.010+0.32%
종가 07/02, 13:00ET시세는 15분 지연됩니다
5.31M시가총액
2.31P/E TTM

자세한 내용은 Nuwellis Inc 회사

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Nuwellis Inc 정보

종목 코드 NUWE
회사 이름Nuwellis Inc
상장일Feb 16, 2012
CEOErb (John L)
직원 수38
유형Ordinary Share
회계 연도 종료Feb 16
주소12988 Valley View Rd
도시EDEN PRAIRIE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호55344
전화19523454200
웹사이트https://www.nuwellis.com/
종목 코드 NUWE
상장일Feb 16, 2012
CEOErb (John L)

Nuwellis Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--

자주 묻는 질문

Nuwellis Inc의 상위 5대 주주는 누구인가요?

Nuwellis Inc의 상위 5대 주주는 다음과 같습니다: Mr. Gregory D. (Greg) Waller

Nuwellis Inc(NUWE)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Nuwellis Inc의 주식을 보유한 기관은 총 20곳이며, 이들이 보유한 주식의 총 가치는 약 135.71K로 전체 발행 주식의 6.78%를 차지합니다. 이는 2025Q4 대비 58953.00 증가한 수치입니다.